NMT to speed up US PFO/stroke trial
This article was originally published in Clinica
Executive Summary
US regulators have given NMT Medical the all-clear to shorten a clinical trial with which the company is seeking to expand the indication of its minimally-invasive cardiac repair device to the potentially lucrative stroke market.